Antisense Therapeutics Limited Stock Last Dividend Paid
Antisense Therapeutics Limited fundamentals help investors to digest information that contributes to Antisense Therapeutics' financial success or failures. It also enables traders to predict the movement of Antisense Pink Sheet. The fundamental analysis module provides a way to measure Antisense Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Antisense Therapeutics pink sheet.
Antisense |
Antisense Therapeutics Limited Company Last Dividend Paid Analysis
Antisense Therapeutics' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
CompetitionBased on the recorded statements, Antisense Therapeutics Limited has a Last Dividend Paid of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
All Next | Launch Module |
Antisense Fundamentals
Return On Equity | -0.43 | |||
Return On Asset | -0.25 | |||
Operating Margin | (3.28) % | |||
Current Valuation | 27.82 M | |||
Shares Outstanding | 669.04 M | |||
Shares Owned By Insiders | 19.30 % | |||
Shares Owned By Institutions | 4.93 % | |||
Price To Earning | (3.62) X | |||
Price To Book | 3.05 X | |||
Price To Sales | 24.46 X | |||
Revenue | 1.78 M | |||
Gross Profit | 1.71 M | |||
EBITDA | (7.52 M) | |||
Net Income | (5.81 M) | |||
Cash And Equivalents | 19.23 M | |||
Cash Per Share | 0.03 X | |||
Total Debt | 227.4 K | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 19.14 X | |||
Book Value Per Share | 0.03 X | |||
Cash Flow From Operations | (7.81 M) | |||
Earnings Per Share | (0.01) X | |||
Number Of Employees | 12 | |||
Beta | 0.67 | |||
Market Capitalization | 41.78 M | |||
Total Asset | 22.44 M | |||
Retained Earnings | (53 M) | |||
Working Capital | 4 M | |||
Current Asset | 5 M | |||
Current Liabilities | 1000 K | |||
Net Asset | 22.44 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Antisense Pink Sheet
If you are still planning to invest in Antisense Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Antisense Therapeutics' history and understand the potential risks before investing.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |